$2,302,000
total plan spend
$3,420,000
traditional PBM estimate
$1,118,000
savings vs traditional
32.7%
cost reduction
Spend Trend & Forecast
AI Insights
Powered by Lava Rock AIAsk Sandi to visualize data
Charts and metrics will appear here
Ask Sandi
Request visualizations of your pharmacy data
Predictive Analytics
AI-powered forecasting based on your plan data
Select a scenario to generate a forecast
GLP-1 / Weight Management Spotlight
Total GLP-1 Spend
$487,000
Members on GLP-1
142
Avg Cost/Member/Mo
$1,143
YoY Growth Rate
34.2%
Monthly GLP-1 Spend Trend
| Drug | Claims | Spend | Trend |
|---|---|---|---|
| Ozempic 1mg | 34 | $196,000 | +28.0% |
| Wegovy 2.4mg | 18 | $124,000 | +52.0% |
| Mounjaro 15mg | 22 | $98,000 | +41.0% |
| Zepbound 15mg | 8 | $41,000 | +89.0% |
| Trulicity 1.5mg | 28 | $28,000 | -12.0% |
Impact Alert: GLP-1 medications represent 25.0% of total pharmacy spend. Projected annual impact: $1,948,000
Cost Avoidance Waterfall
Top 10 Drugs by Spend
Humira
Specialty
Ozempic
Diabetes
Eliquis
Cardiovascular
Imatinib
Oncology
Jardiance
Diabetes
Atorvastatin
Cardiovascular
Metformin
Diabetes
Sertraline
Mental Health
Omeprazole
GI
Lisinopril
Cardiovascular
Brand vs Generic Mix
Therapeutic Categories
Industry Benchmarks
Specialty Drug Tracker
Humira
$23.7K/mo
Stelara
$18.4K/mo
Keytruda
$14.2K/mo
Revlimid
$12.8K/mo
Xarelto
$9.6K/mo
Member Cost Distribution
Fiduciary & Transparency Scorecard
Transparency Grade
7 of 7 metrics passing
Spread Pricing
Rebate Passthrough
Admin Fee PMPM
$8.50
vs industry $28.50
| Metric | RxDune | Traditional PBM | Status |
|---|---|---|---|
| Spread Pricing | $0.00 | $4.50–$22 PMPM | ✓ |
| Rebate Passthrough | 100% | 55–70% | ✓ |
| Admin Fee (PMPM) | $8.50 | $22–$45 | ✓ |
| AWP Discount Transparency | Full disclosure | Opaque | ✓ |
| MAC List Access | Published | Proprietary | ✓ |
| Clinical Rebate Steering | None | Common | ✓ |
| Audit Rights | Unlimited | Limited / Annual | ✓ |
ERISA Compliance
100% pass-through model with complete audit trail available. All pricing and rebate data is transparent and fiduciary-aligned.
High-Cost Claimant Alerts
Members requiring intervention
MBR-4821
Keytruda
$14,200/mo
PAP Eligibility ReviewMBR-7762
Humira
$8,900/mo
Biosimilar Switch — HadlimaMBR-1093
Ozempic + Farxiga
$4,200/mo
Therapeutic Alternatives ReviewRebate Transparency
Estimated Rebates YTD
$31,815
Rebate Realization Rate
87.2%
RxDune Rebate Passthrough
100%
Industry avg: 55-70%
Rebate Estimates by Drug
100% passthrough| Drug | Type | Total Spend | Est. Rebate/Claim | Claims | Total Est. Rebate |
|---|---|---|---|---|---|
| Humira | Specialty | $284,000 | $650 | 12 | $7,800 |
| Eliquis | Brand | $142,000 | $95 | 78 | $7,410 |
| Keytruda | Specialty | $242,000 | $650 | 8 | $5,200 |
| Jardiance | Brand | $98,000 | $95 | 45 | $4,275 |
| Revlimid | Specialty | $89,000 | $650 | 6 | $3,900 |
| Ozempic | Brand | $196,000 | $95 | 34 | $3,230 |
Plan Performance: RxDune vs Traditional
Key Financial Metrics
| Metric | RxDune | Traditional | Variance |
|---|---|---|---|
| PMPM Cost | $37.59 | $59.82 | ▼37.2% |
| Avg Cost/Brand Rx | $237.86 | $412.50 | ▼42.3% |
| Avg Cost/Generic Rx | $6.26 | $8.42 | ▼25.7% |
| Generic Dispensing Rate | 72.4% | 61.2% | ▲18.3% |
Contract Benchmarking & Competitive Analysis
| Metric | RxDune | Big 3 PBMs (Avg) | Independent PBMs (Avg) | Your Current RFP |
|---|---|---|---|---|
| PMPM | $37.59 | $59.82 | $47.14 | $54.08 |
| Estimated Spread | $0.00 | $4.50 | $2.20 | $3.80 |
| Rebate Retention % | 0% | 35% | 22% | 30% |
| Admin Fee PMPM | $8.50 | $28.50 | $18.00 | $22.00 |
| Generic Discount (AWP-%) | AWP-88% | AWP-82% | AWP-85% | AWP-83% |
| Brand Discount (AWP-%) | AWP-24% | AWP-17% | AWP-20% | AWP-18% |
| Total Annual Savings vs. | Baseline | +$266.76/yr | +$114.60/yr | +$197.88/yr |
Employer Group Segmentation
| Segment | Members | Spend | PMPM | Generic Rate | Specialty % |
|---|---|---|---|---|---|
| Corporate HQ | 8,420 | $892,000 | $35.30 | 76.2% | 6.4% |
| Manufacturing | 5,180 | $624,000 | $40.15 | 68.4% | 12.1% |
| Distribution Centers | 3,640 | $412,000 | $37.73 | 71.8% | 8.9% |
| Field Sales | 2,172 | $268,000 | $41.12 | 69.1% | 11.2% |
| Remote / WFH | 1,000 | $106,000 | $35.33 | 78.4% | 4.8% |
Member Experience & Satisfaction
Overall Score
Formulary Disruption
4.2%
Lower is better
Network Access
94
Prior Auth Satisfaction
82
Copay Predictability
91
Score vs. Industry Benchmark
Prior Auth Tracker
12
Pending
156
Approved
8
Denied
1.2 days
Avg TAT
Formulary Compliance
94.2%
Formulary Compliance Rate
2,580
On-Formulary
159
Off-Formulary
Renewal Projection & Scenario Modeling
Toggle scenarios to model projected plan year impact
Current Annual
$2,302,000
Base Projected
$2,366,456
Adjusted Projected
$2,366,456
Savings vs Traditional
$128,912
What-If Scenarios
Adjudicated Claims Feed
| Member ID | Fill Date | Drug Name | Brand / Generic | Fill Location | Channel | Plan Paid | Member Copay | Savings vs Traditional |
|---|---|---|---|---|---|---|---|---|
| MBR-2198 | 2026-03-25 | Imatinib Mesylate 400mg | Specialty | CostPlusDrugs | Cost Plus | $1,656.00 | FREE | ↓$63,667 |
| MBR-4521 | 2026-03-24 | Metformin 500mg | Generic | CVS Pharmacy | Retail | $4.20 | $5.00 | ↓$2.8 |
| MBR-7834 | 2026-03-24 | Lisinopril 10mg | Generic | Walgreens | Retail | $3.80 | $5.00 | ↓$3.2 |
| MBR-3156 | 2026-03-23 | Humira 40mg | Specialty | Accredo | Specialty | $2,847.00 | $150.00 | ↓$4,123 |
| MBR-6892 | 2026-03-23 | Atorvastatin 20mg | Generic | Express Scripts Mail | Mail Order | $8.40 | $10.00 | ↓$26.6 |
| MBR-1247 | 2026-03-22 | Ozempic 1mg | Brand | CVS Specialty | Specialty | $892.00 | $75.00 | ↓$433 |
| MBR-5673 | 2026-03-22 | Amlodipine 5mg | Generic | Rite Aid | Retail | $4.50 | $5.00 | ↓$5.5 |
| MBR-8234 | 2026-03-21 | Eliquis 5mg | Brand | Walgreens | Retail | $285.00 | $45.00 | ↓$190 |
| MBR-4089 | 2026-03-21 | Omeprazole 20mg | Generic | Amazon Pharmacy | Mail Order | $6.20 | $5.00 | ↓$13.8 |
| MBR-9156 | 2026-03-20 | Jardiance 25mg | Brand | OptumRx Mail | Mail Order | $412.00 | $50.00 | ↓$188 |
| MBR-2567 | 2026-03-20 | Sertraline 50mg | Generic | CVS Pharmacy | Retail | $5.80 | $5.00 | ↓$9.2 |
| MBR-7412 | 2026-03-19 | Keytruda 100mg | Specialty | Biologics by McKesson | Specialty | $9,245.00 | $250.00 | ↓$12,505 |
| MBR-3890 | 2026-03-19 | Gabapentin 300mg | Generic | Walmart Pharmacy | Retail | $7.20 | $5.00 | ↓$7.8 |
| MBR-6123 | 2026-03-18 | Trulicity 1.5mg | Brand | Express Scripts Mail | Mail Order | $678.00 | $60.00 | ↓$362 |
| MBR-1789 | 2026-03-18 | Levothyroxine 50mcg | Generic | Rite Aid | Retail | $4.80 | $5.00 | ↓$10.2 |
| MBR-5234 | 2026-03-17 | Stelara 45mg | Specialty | CVS Specialty | Specialty | $6,892.00 | $200.00 | ↓$8,908 |
| MBR-8901 | 2026-03-17 | Metoprolol 25mg | Generic | CVS Pharmacy | Retail | $4.00 | $5.00 | ↓$6 |
| MBR-2345 | 2026-03-16 | Xarelto 20mg | Brand | Walgreens | Retail | $312.00 | $45.00 | ↓$193 |
| MBR-6789 | 2026-03-16 | Losartan 50mg | Generic | Amazon Pharmacy | Mail Order | $5.60 | $5.00 | ↓$9.4 |
| MBR-4567 | 2026-03-15 | Revlimid 25mg | Specialty | Accredo | Specialty | $18,456.00 | $300.00 | ↓$6,244 |
Showing 20 of 2,739 claims